Current therapies for RA include antirheumatic drugs (DMARDs), anti-tumor necrosis factor-alpha inhibitors (e.g., adalimumab, etanercept, and infliximab) and non-tumor necrosis factor inhibitors (e.g., ababtreotide, rituximab, toximab) (4). Here, TNF is linked to rheumatoid arthritis.